![Olivier Gouédard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Olivier Gouédard
Geschäftsführer bei Cytovia Therapeutics, Inc.
Aktive Positionen von Olivier Gouédard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cytovia Therapeutics, Inc.
![]() Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Geschäftsführer | 22.06.2021 | - |
Karriereverlauf von Olivier Gouédard
Ausbildung von Olivier Gouédard
New York University | Masters Business Admin |
Université Paris-Saclay | Undergraduate Degree |
University of Rennes | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Frankreich | 3 |
Operativ
Chief Operating Officer | 1 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Cytovia Therapeutics, Inc.
![]() Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Olivier Gouédard
- Erfahrung